Key Points
- H. B. Fuller VP Nathan Weaver sold 9,561 shares at an average price of $62.06, generating approximately $593,356 and reducing his direct holdings by 44.89% to 11,739 shares.
- The company reported quarterly EPS of $1.41, exceeding estimates of $1.37, while revenue reached $950.27 million, up 5.8% year over year and above analyst expectations.
- H. B. Fuller declared a quarterly dividend of $0.245 per share, equivalent to an annualized $0.98 payout and a 1.6% yield; analysts maintain a “Moderate Buy” consensus with an average price target of $67.86.
H. B. Fuller Company (NYSE:FUL - Get Free Report) VP Nathan Weaver sold 9,561 shares of the firm's stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $62.06, for a total transaction of $593,355.66. Following the completion of the sale, the vice president directly owned 11,739 shares of the company's stock, valued at approximately $728,522.34. This represents a 44.89% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
H. B. Fuller Stock Performance
FUL stock opened at $60.11 on Thursday. The company has a 50 day moving average price of $59.30 and a 200 day moving average price of $60.48. H. B. Fuller Company has a fifty-two week low of $48.71 and a fifty-two week high of $68.63. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.80 and a quick ratio of 1.12. The stock has a market capitalization of $3.23 billion, a PE ratio of 18.44, a price-to-earnings-growth ratio of 0.67 and a beta of 0.98.
H. B. Fuller (NYSE:FUL - Get Free Report) last announced its quarterly earnings data on Thursday, June 25th. The specialty chemicals company reported $1.41 EPS for the quarter, beating analysts' consensus estimates of $1.37 by $0.04. The firm had revenue of $950.27 million for the quarter, compared to analyst estimates of $924.83 million. H. B. Fuller had a return on equity of 12.18% and a net margin of 5.29%.The business's quarterly revenue was up 5.8% compared to the same quarter last year. During the same period last year, the company earned $1.18 EPS. Analysts forecast that H. B. Fuller Company will post 4.87 EPS for the current year.
H. B. Fuller Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Thursday, August 13th. Stockholders of record on Thursday, July 30th will be paid a dividend of $0.245 per share. This represents a $0.98 annualized dividend and a dividend yield of 1.6%. The ex-dividend date of this dividend is Thursday, July 30th. H. B. Fuller's dividend payout ratio is 30.06%.
H. B. Fuller News Summary
Here are the key news stories impacting H. B. Fuller this week:
- Positive Sentiment: Ancora’s cash offer could provide H.B. Fuller with substantial proceeds, potentially allowing the company to reduce debt, strengthen its balance sheet or return capital to shareholders. The proposal also signals that the activist investor believes the BAS business is worth more than its current contribution to the company. Reuters article
- Positive Sentiment: H.B. Fuller confirmed receipt of the unsolicited proposal, creating the possibility of a strategic review or negotiations that could result in a premium valuation for the BAS segment. H.B. Fuller proposal confirmation
- Positive Sentiment: Shareholders of Advanced Medical Solutions Group approved the resolutions related to H.B. Fuller’s cash takeover, supporting progress on the company’s broader strategic expansion. Advanced Medical Solutions shareholder vote
- Neutral Sentiment: Analysts and valuation commentary continue to suggest that FUL may be undervalued, but this view is based primarily on earnings estimates and valuation metrics rather than a new company announcement. Zacks valuation analysis
- Negative Sentiment: The BAS proposal is unsolicited and not binding, so there is no assurance that a transaction will occur. Selling the segment could also reduce H.B. Fuller’s scale and earnings diversification, while activist pressure may increase uncertainty around management’s strategy and debt levels. Ancora proposal letter
- Negative Sentiment: Vice President Nathan D. Weaver sold 9,561 shares worth approximately $593,000, reducing his position by nearly 45%. While one insider sale is not conclusive, it may modestly weigh on sentiment. SEC insider transaction filing
Wall Street Analyst Weigh In
A number of analysts recently commented on FUL shares. UBS Group set a $69.00 price objective on H. B. Fuller in a research report on Friday, June 26th. Raymond James Financial set a $67.00 target price on shares of H. B. Fuller in a research report on Friday, June 26th. Citigroup raised their target price on shares of H. B. Fuller from $70.00 to $75.00 and gave the company a "buy" rating in a research note on Tuesday, June 30th. Royal Bank Of Canada set a $58.00 price target on shares of H. B. Fuller in a research report on Wednesday, May 27th. Finally, Deutsche Bank Aktiengesellschaft boosted their price target on shares of H. B. Fuller from $70.00 to $72.00 and gave the stock a "buy" rating in a research note on Tuesday, June 30th. One equities research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat, H. B. Fuller has an average rating of "Moderate Buy" and a consensus price target of $67.86.
Get Our Latest Analysis on FUL
Institutional Inflows and Outflows
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Jefferies Financial Group Inc. bought a new stake in H. B. Fuller in the fourth quarter valued at about $2,644,000. Congruence Capital LLC bought a new position in H. B. Fuller during the fourth quarter worth about $10,048,000. Norges Bank acquired a new position in shares of H. B. Fuller during the 4th quarter worth about $44,203,000. Kennedy Capital Management LLC grew its position in shares of H. B. Fuller by 43.4% during the 4th quarter. Kennedy Capital Management LLC now owns 630,194 shares of the specialty chemicals company's stock worth $37,471,000 after buying an additional 190,750 shares during the period. Finally, UBS Group AG grew its position in shares of H. B. Fuller by 35.0% during the 4th quarter. UBS Group AG now owns 1,108,261 shares of the specialty chemicals company's stock worth $65,897,000 after buying an additional 287,390 shares during the period. 95.93% of the stock is currently owned by institutional investors.
H. B. Fuller Company Profile
(
Get Free Report)
H. B. Fuller Company, founded in 1887 and headquartered in St. Paul, Minnesota, is a global adhesives and specialty chemical solutions provider serving a wide array of industries. The company develops, manufactures and markets adhesive technologies, sealants, polymers and related chemical products designed to enhance product performance, sustainability and manufacturing efficiency.
Fuller's product portfolio spans multiple market segments, including packaging and converting, general industrial assembly, electronics, transportation, hygiene and construction.
Read More
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
